Eva Pharma

• NCT06286098

  Collaborator, Phase 3, Enrolling by invitation, 50 people, 29 Feb 2024

• NCT05813496

  Phase 4, Completed, 430 people, 14 Apr 2023

• NCT05798715

  Collaborator, Phase 1, Completed, 30 people, 5 Apr 2023

• NCT03949673

  Collaborator, Phase 2, Terminated, 23 people, 14 May 2019

• NCT03304379

  Collaborator, Phase 3, Completed, 1,650 people, 9 Oct 2017

• NCT02816970

  Collaborator, Phase 1, Completed, 24 people, 29 Jun 2016

• NCT02805842

  Collaborator, Phase 3, Status unknown, 60 people, 20 Jun 2016

• Efficacy and safety of mazdutide in adults with obesity or overweight: a US-based, multicentre, phase 2, randomised, placebo-controlled clinical trial

  Consulting or advice, 21 Aug 2026

Sources: pubmed.ncbi.nlm.nih.gov